Terms: = Bone cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359
253 results:
1. Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.
Rosenberg AGW; Mochèl K; Hähner LM; Ruules L; Davidse K; Bos-Roubos AG; van Dijk SA; Zillikens MC; Taal W; van der Lely AJ; de Graaff LCG
Front Endocrinol (Lausanne); 2023; 14():1119159. PubMed ID: 38560379
[TBL] [Abstract] [Full Text] [Related]
2. Genetic disorders and insulinoma/glucagonoma.
Marini F; Giusti F; Brandi ML
Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38552306
[TBL] [Abstract] [Full Text] [Related]
3. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population.
Patrizi S; Miele E; Falcone L; Vallese S; Rossi S; Barresi S; Giovannoni I; Pedace L; Nardini C; Masier I; Abballe L; Cacchione A; Russo I; Di Giannatale A; Di Ruscio V; Salgado CM; Mastronuzzi A; Ciolfi A; Tartaglia M; Milano GM; Locatelli F; Alaggio R
Clin Epigenetics; 2024 Jan; 16(1):9. PubMed ID: 38178234
[TBL] [Abstract] [Full Text] [Related]
4. Determining the risk of spinal pathology progression in neurofibromatosis type 1 patients - a national tertiary neurofibromatosis type 1 centre study.
Robinson D; Biswas S; Torrie C; MacArthur J; Snowdon E; Sial M; Sarkar V; George KJ
Clin Neurol Neurosurg; 2023 Nov; 234():107985. PubMed ID: 37778105
[TBL] [Abstract] [Full Text] [Related]
5. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
6. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
[TBL] [Abstract] [Full Text] [Related]
8. [A case of orbital rhabdomyosarcoma combined with neurofibromatosis type 1 in a child].
Gao L; Zhou JC; Wang Y
Zhonghua Yan Ke Za Zhi; 2023 Apr; 59(4):305-309. PubMed ID: 37012595
[TBL] [Abstract] [Full Text] [Related]
9. nf1-Related MicroRNA Gene Polymorphisms and the Susceptibility to Soft Tissue Sarcomas: A Case-Control Study.
Zhang P; Huang L; Li X; Hu F; Niu X; Sun Y; Yao W; Tian W
DNA Cell Biol; 2023 May; 42(5):229-238. PubMed ID: 36989515
[TBL] [Abstract] [Full Text] [Related]
10. Malignant peripheral nerve sheath tumours in a patient with Neurofibromatosis-1.
Iqbal F; Jamaluddin M; Bukhari F; Islam OS
J Pak Med Assoc; 2023 Feb; 73(2):393-395. PubMed ID: 36800734
[TBL] [Abstract] [Full Text] [Related]
11. Audiometric and Otologic Findings in Children and Young Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas.
Idowu V; Christensen J; Gross AM; Dombi E; Miles JR; King K; Chisholm J; Zalewski C; Baldwin A; Whitcomb P; Burgess C; Widemann BC; Brewer CC; Kim HJ
Laryngoscope; 2023 Oct; 133(10):2770-2778. PubMed ID: 36583617
[TBL] [Abstract] [Full Text] [Related]
12. A Review of Spinal Lesions in Neurofibromatosis Type 1 in a Large Neurofibromatosis Type 1 Center.
Sial M; George KJ
World Neurosurg; 2023 Jan; 169():e157-e163. PubMed ID: 36334707
[TBL] [Abstract] [Full Text] [Related]
13. Malignant peripheral nerve sheath tumor of the maxilla: Case report and review of the literature with emphasis on its poor prognosis.
Oh KY; Hong SD
Oral Oncol; 2022 Dec; 135():106211. PubMed ID: 36257181
[TBL] [Abstract] [Full Text] [Related]
14. Pheochromocytoma Turned Malignant During Pregnancy in a Patient With Neurofibromatosis Type I - A Case Report and Systematic Review of the Current Literature.
Zeitler C; Fuderer L; Schmitz K; Arora R; Dammerer D
Anticancer Res; 2022 Sep; 42(9):4647-4656. PubMed ID: 36039448
[TBL] [Abstract] [Full Text] [Related]
15. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
de Blank PMK; Gross AM; Akshintala S; Blakeley JO; Bollag G; Cannon A; Dombi E; Fangusaro J; Gelb BD; Hargrave D; Kim A; Klesse LJ; Loh M; Martin S; Moertel C; Packer R; Payne JM; Rauen KA; Rios JJ; Robison N; Schorry EK; Shannon K; Stevenson DA; Stieglitz E; Ullrich NJ; Walsh KS; Weiss BD; Wolters PL; Yohay K; Yohe ME; Widemann BC; Fisher MJ
Neuro Oncol; 2022 Nov; 24(11):1845-1856. PubMed ID: 35788692
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
Solares I; Vinal D; Morales-Conejo M
Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
[TBL] [Abstract] [Full Text] [Related]
17. Recurrent Mandibular Giant Cell Lesion in Neurofibromatosis Type 1: Second Hit Mutation on the
Friedrich RE; Luebke AM; Schüller U; Hagel C; Kohlrusch FK; Wieland I; Zenker M
Anticancer Res; 2022 Jun; 42(6):2945-2952. PubMed ID: 35641267
[TBL] [Abstract] [Full Text] [Related]
18. Gliosarcoma with osteosarcomatous component: A case report and short review illustration.
Chen Y; Zhou S; Zhou X; Dai X; Wang L; Chen P; Zhao S; Shi C; Xiao S; Dong J
Pathol Res Pract; 2022 Apr; 232():153837. PubMed ID: 35278815
[TBL] [Abstract] [Full Text] [Related]
19. Spinal screening, malignancy, medical therapy, and surgical correction of deformity in pediatric patients with neurofibromatosis type 1: a systematic review.
Suresh KV; Xu AL; Groves ML; Sponseller PD
J Pediatr Orthop B; 2022 Nov; 31(6):572-582. PubMed ID: 35132000
[TBL] [Abstract] [Full Text] [Related]
20. Diagnosis and treatment of nail melanoma: a review of the clinicopathologic, dermoscopic, and genetic characteristics.
Darmawan CC; Ohn J; Mun JH; Kim S; Lim Y; Jo SJ; Kim YG; Kim B; Seong MW; Kim BJ; Lee C; Kwak Y; Chung HJ; Virós A; Lee DY
J Eur Acad Dermatol Venereol; 2022 May; 36(5):651-660. PubMed ID: 35098589
[TBL] [Abstract] [Full Text] [Related]
[Next]
